FOSTER CITY, Calif.--(BUSINESS WIRE)--Oct. 25, 2018--
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the company’s
Board of Directors has declared a cash dividend of $0.57 per share of
common stock for the fourth quarter of 2018. The dividend is payable on
December 28, 2018, to stockholders of record at the close of business on
December 14, 2018. Future dividends will be subject to Board approval.
About Gilead Sciences
Gilead Sciences, Inc. is a research-based biopharmaceutical company that
discovers, develops and commercializes innovative medicines in areas of
unmet medical need. The company strives to transform and simplify care
for people with life-threatening illnesses around the world. Gilead has
operations in more than 35 countries worldwide, with headquarters in
Foster City, California.
For more information on Gilead Sciences, please visit the company’s
website at www.gilead.com,
follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs
at 1-800-GILEAD-5 or 1-650-574-3000.
View source version on businesswire.com: https://www.businesswire.com/news/home/20181025005721/en/
Source: Gilead Sciences, Inc.
Gilead Sciences, Inc.
Sung Lee, 650-524-7792